生物素A在疹简单角膜炎的治疗潜力
Nan Zhou1, Deyuan Zheng2, Qiao You3
1Department of Ophthalmology, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2023
概括
生物素A (BCA) 是一种天然化合物,通过抑制HSV-1复制和减少炎症,有效地对抗简单疹角膜炎 (HSK). BCA显示出作为这种致盲眼病的新型治疗方法的前景.
科学领域:
- 眼科医生 眼科 眼科
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由HSV-1引起的简单疹角膜炎 (HSK) 是导致失明的主要原因.
- 目前的治疗方法,如阿西克洛维尔 (ACV) 面临抗药性,皮质类固醇有副作用.
- 紧急需要新的抗病毒疗法来治疗HSK.
研究的目的:
- 调查生物素A (BCA) 对HSK的治疗潜力.
- 为了评估BCA的抗病毒,抗炎,抗氧化应激和抗丧作用.
主要方法:
- 在体外评估BCA对HSV-1复制的影响.
- 分析BCA对促炎因素 (TNF-α,RANTES,IL-1β,IL-6) 的影响.
- 在体内研究,使用HSK的小鼠模型,用BCA眼滴治疗.
主要成果:
- 在体外,BCA显著抑制HSV-1复制,主要是在早期感染阶段.
- BCA降低了关键的促炎细胞因子的调节,并减轻了氧化应激和亡.
- 在体内,BCA治疗减少了HSK小鼠的眼睛表面病变,病毒载量和炎症.
结论:
- 生物素A显示出对HSK的多方面的保护作用.
- BCA表现出强大的抗病毒和抗炎性质,与HSK治疗有关.
- 在开发新的HSK疗法方面,BCA是有前途的天然化合物.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
709
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
709
Direct-Acting Cholinergic Agonists: Therapeutic Uses
784
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
784
Depolarizing Blockers: Pharmocokinetics
347
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
347


